Eyelumina

New Capabilities

As of September 2026: Seeking investment for translational development and future clinical trials

Blind mice given a new eye drop regained an instinct they had lost: avoiding bright areas. The drug, called prosthe6, restored light perception in animal models of age-related macular degeneration and retinitis pigmentosa within hours of a single dose. The treated mice avoided bright zones at light levels comparable to indoor lighting or a cloudy day.

Updated Sep 9